ProfileGDS4459 / ENSG00000103876
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 86% 81% 93% 87% 92% 86% 94% 95% 93% 95% 78% 94% 90% 80% 94% 83% 81% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.6786
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.9781
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.8993
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.5987
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 57.692
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.7186
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 77.9394
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 88.2295
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.7893
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 108.1795
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.8678
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.1394
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.3790
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.8680
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.0794
GSM623479group B, liver allograft wedge biopsie placebo treatment 66.2483
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.0781